• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对亚历山大·科恩的采访。

Interview with Alexander Cohen.

作者信息

Cohen Alexander Ander

机构信息

Department of Haematological Medicine, Guy's & St Thomas' NHS Foundation Trust, King's College London, Westminster Bridge Road, London, UK.

出版信息

Future Cardiol. 2017 May;13(3):207-209. doi: 10.2217/fca-2017-0024. Epub 2017 Jun 1.

DOI:10.2217/fca-2017-0024
PMID:28569545
Abstract

Ander Cohen speaks to Adam Price-Evans, Commissioning Editor of Future Cardiology: Alexander (Ander) Cohen MBBS (Hons), MSc, MD, FRACP is a vascular physician and epidemiologist at Guy's and St Thomas' Hospital, King's College (London, UK). He graduated with honors in medicine and honors in surgery from the University of Melbourne, Australia, and became a fellow of the Royal Australasian College of Physicians in 1990. He was awarded an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine, University of London in 1991 with a thesis on the metabolic syndrome in South-Asian populations. In 1998, he was awarded an MD with a thesis on the epidemiology of venous thromboembolism and thromboprophylaxis. In addition to his clinical work, he is involved in designing, managing and analyzing clinical trials from Phase I to IV. He is the Chairman and a member of many international steering committees for multicenter trials, epidemiological and pharmacoeconomic studies, and was previously the Director of Clinical Research and an Epidemiologist in Thrombosis Research at King's College Hospital.

摘要

安德·科恩与《未来心脏病学》的委托编辑亚当·普莱斯-埃文斯交谈:亚历山大(安德)·科恩,医学学士(优等)、理学硕士、医学博士、澳大利亚皇家内科医师学会会员,是英国伦敦国王学院盖伊和圣托马斯医院的血管内科医生兼流行病学家。他以优异成绩毕业于澳大利亚墨尔本大学医学专业及外科专业,并于1990年成为澳大利亚皇家内科医师学会会员。1991年,他在伦敦大学卫生与热带医学院获得流行病学理学硕士学位,论文主题是南亚人群的代谢综合征。1998年,他凭借一篇关于静脉血栓栓塞症流行病学及血栓预防的论文获得医学博士学位。除了临床工作外,他还参与从I期到IV期临床试验的设计、管理和分析。他是多个多中心试验、流行病学和药物经济学研究国际指导委员会的主席及成员,曾任国王学院医院临床研究主任和血栓形成研究领域的流行病学家。

相似文献

1
Interview with Alexander Cohen.对亚历山大·科恩的采访。
Future Cardiol. 2017 May;13(3):207-209. doi: 10.2217/fca-2017-0024. Epub 2017 Jun 1.
2
A vascular physician's view of venous thromboembolism and apixaban.
Future Cardiol. 2014 Nov;10(6):679-81. doi: 10.2217/fca.14.66.
3
Practical management of rivaroxaban for the treatment of venous thromboembolism.利伐沙班治疗静脉血栓栓塞症的实际管理
Clin Appl Thromb Hemost. 2015 May;21(4):309-18. doi: 10.1177/1076029613503397. Epub 2013 Sep 19.
4
Thromboprophylaxis by rivaroxaban, aspirin, both, or placebo after hospitalization for medical illness.因内科疾病住院后,使用利伐沙班、阿司匹林、两者联合或安慰剂进行血栓预防。
Thromb Res. 2019 Aug;180:62-63. doi: 10.1016/j.thromres.2019.06.002. Epub 2019 Jun 11.
5
Uses of the Twins UK genetic database.英国双胞胎基因数据库的用途。
Per Med. 2007 Nov;4(4):457-461. doi: 10.2217/17410541.4.4.457.
6
Interview: Key questions in pain research: clinical observations informing research and vice versa.访谈:疼痛研究中的关键问题:临床观察为研究提供信息,反之亦然。
Pain Manag. 2011 Mar;1(2):123-5. doi: 10.2217/pmt.11.10.
7
Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.直接Xa因子抑制剂(利伐沙班和阿哌沙班)与依诺肝素用于全膝关节置换术后预防静脉血栓栓塞:6项随机临床试验的荟萃分析
Thromb Res. 2015 May;135(5):816-22. doi: 10.1016/j.thromres.2015.02.008. Epub 2015 Feb 12.
8
[The EINSTEIN CHOICE study].[爱因斯坦选择研究]
G Ital Cardiol (Rome). 2017 Sep;18(9):613-617. doi: 10.1714/2741.27942.
9
The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.利伐沙班用于出院后有静脉血栓栓塞高风险内科患者的MARINER试验。设计、原理及临床意义。
Thromb Haemost. 2016 Jun 2;115(6):1240-8. doi: 10.1160/TH15-09-0756. Epub 2016 Feb 4.
10
Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.比较利伐沙班与传统抗凝剂治疗静脉血栓栓塞症患者的住院时间。
Lung. 2016 Aug;194(4):605-11. doi: 10.1007/s00408-016-9898-8. Epub 2016 May 18.